| A role for interleukin-2 trans-presentation in dendritic cell–mediated T cell activation in humans, as revealed by daclizumab therapy SC Wuest, JH Edwan, JF Martin, S Han, JSA Perry, CM Cartagena, ... Nature medicine 17 (5), 604-609, 2011 | 313 | 2011 |
| Inhibition of LTi cell development by CD25 blockade is associated with decreased intrathecal inflammation in multiple sclerosis JSA Perry, S Han, Q Xu, ML Herman, LB Kennedy, G Csako, B Bielekova Science translational medicine 4 (145), 145ra106-145ra106, 2012 | 163 | 2012 |
| SNAI1 is involved in the proliferation and migration of glioblastoma cells SP Han, JH Kim, ME Han, HE Sim, KS Kim, S Yoon, SY Baek, BS Kim, ... Cellular and molecular neurobiology 31, 489-496, 2011 | 137 | 2011 |
| Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases S Han, YC Lin, T Wu, AD Salgado, I Mexhitaj, SC Wuest, E Romm, ... The Journal of Immunology 192 (6), 2551-2563, 2014 | 123 | 2014 |
| The effects of interleukin-2 on immune response regulation RS Waters, JSA Perry, SP Han, B Bielekova, T Gedeon Mathematical Medicine and Biology: a Journal of the IMA 35 (1), 79-119, 2018 | 65 | 2018 |
| Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ‐12420), a novel potassium … S Han, HY Choi, YH Kim, JY Nam, B Kim, GS Song, HS Lim, KS Bae Alimentary pharmacology & therapeutics 50 (7), 751-759, 2019 | 63 | 2019 |
| Development of R packages:‘NonCompart’and ‘ncar’for noncompartmental analysis (NCA) H Kim, S Han, YS Cho, SK Yoon, KS Bae Translational and Clinical Pharmacology 26 (1), 10, 2018 | 15 | 2018 |
| Effect of food on the pharmacokinetics and pharmacodynamics of a single oral dose of tegoprazan S Han, HY Choi, YH Kim, JY Nam, B Kim, GS Song, HS Lim, KS Bae Clinical Therapeutics 43 (8), 1371-1380, 2021 | 10 | 2021 |
| Single-dose intravenous safety, tolerability, and pharmacokinetics and absolute bioavailability of LCB01-0371 YS Cho, HS Lim, S Han, SK Yoon, H Kim, YL Cho, HS Nam, KS Bae Clinical Therapeutics 41 (1), 92-106, 2019 | 9 | 2019 |
| Usefulness of Bnet, a simple linear metric in discerning Torsades De pointes risks in 28 CiPA drugs S Han, S Han, KS Kim, HA Lee, DS Yim Frontiers in Pharmacology 10, 1419, 2019 | 8 | 2019 |
| Comparison of pharmacodynamics between tegoprazan and dexlansoprazole regarding nocturnal acid breakthrough: a randomized crossover study S Han, HY Choi, YH Kim, SC Choi, S Kim, JY Nam, B Kim, GS Song, ... Gut and Liver 17 (1), 92, 2023 | 7 | 2023 |
| Urinary profile of endogenous gamma-hydroxybutyric acid and its biomarker metabolites in healthy korean females: Determination of age-dependent and intra-individual variability … S Kim, S Choi, MS Lee, M Kim, M Park, S Han, S Han, HS Lee, S Lee Frontiers in Pharmacology 13, 853971, 2022 | 4 | 2022 |
| First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of a Neuroprotective Poly (ADP‐ribose) Polymerase‐1 Inhibitor, JPI-289, in Healthy Volunteers S Han, YH Kim, HY Choi, DJ Soh, J Kim, J Nam, JW Kim, KS Bae, HS Lim Drug Design, Development and Therapy, 3189-3199, 2020 | 4 | 2020 |
| Safety, tolerability, pharmacokinetics, and pharmacodynamics of escalating single and multiple oral doses of CJ-12420 (tegoprazan), a novel potassium-competitive acid blocker … S Han, HY Choi, YH Kim, JY Nam, GS Song, HS Lim, KS Bae Clinical Therapeutics 39 (8), e97-e98, 2017 | 4 | 2017 |
| First-in-human, double-blind, randomized controlled trial of an oral dose of GnRH antagonist TU2670 in healthy women S Han, YS Cho, SK Yoon, KS Lim, SH Cho, JW Kim, S Choe, J Jung, ... The Journal of Clinical Endocrinology & Metabolism 106 (3), e1111-e1120, 2021 | 3 | 2021 |
| Pharmacokinetic and pharmacodynamic modeling and simulation analysis of Ctb-001, a recently developed generic of bivalirudin S Han, YH Kim, HY Choi, MJ Kim, WJ Kim, H Park, KS Bae, HS Lim Pharmaceutical Research 36, 1-9, 2019 | 3 | 2019 |
| Caffsim: simulation of plasma caffeine concentrations implemented as an R package and Web-applications S Han, YS Cho, SK Yoon, H Kim, KS Bae Translational and Clinical Pharmacology 25 (3), 141, 2017 | 3 | 2017 |
| Prediction of the human in vivo antiplatelet effect of S-and R-indobufen using population pharmacodynamic modeling and simulation based on in vitro platelet aggregation test YH Noh, S Han, S Choe, JA Jung, AK Hwang, HS Lim Translational and Clinical Pharmacology 26 (4), 160, 2018 | 2 | 2018 |
| Establishing Rationale for the Clinical Development of Cell Therapy Products: Consensus between Risk and Benefit S Han, HW Yim, H Jeong, S Choi, S Han International Journal of Stem Cells 16 (1), 16, 2023 | 1 | 2023 |
| Disease Progression Modeling Analysis of the Change of Bone Mineral Density by Postoperative Hormone Therapies in Postmenopausal Patients With Early Breast Cancer SK Yoon, KS Bae, YS Cho, S Han, H Kim, HS Lim The Journal of Clinical Pharmacology 59 (11), 1543-1550, 2019 | 1 | 2019 |
Kyun-Seop BaeUniversity of Ulsan在 amc.seoul.kr 的电子邮件经过验证
